Actively Recruiting
FAST-FORWARD vs HAI5
Led by University Hospital, Ghent · Updated on 2024-06-05
740
Participants Needed
2
Research Sites
500 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Randomized comparison between the FAST-FORWARD schedule and the HAI5 schedule for breast cancer radiotherapy in 5 fractions.
CONDITIONS
Official Title
FAST-FORWARD vs HAI5
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histopathological diagnosis of breast cancer
- Age 18 years or older
- Male or female
- Treated with breast conserving surgery or mastectomy with curative intent
- Multidisciplinary decision of adjuvant radiotherapy after surgery
You will not qualify if you...
- Presence of distant metastases
- Decision to have preoperative radiotherapy
- Decision for partial breast irradiation
- Positive resection margins ('ink on tumour')
- Indication for boost on lymph node(s)
- History of thoracic or ipsilateral axillary radiotherapy, including radiotherapy of the contralateral breast or chest wall
- Need for bilateral irradiation
- Breast reconstruction or expander
- Patients unlikely to comply with the protocol, such as inability or unwillingness to complete questionnaires at different times
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Universitary Hospital
Ghent, Belgium, 9000
Not Yet Recruiting
2
University Hospital Ghent
Ghent, Belgium, 9000
Actively Recruiting
Research Team
L
Liv Veldeman, MD, PhD
CONTACT
E
Emma Van Damme
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here